Clin2
NCT03590821Possibly a fitNot yet recruiting

Aspirin timing study for healthy adults

Healthy

Treatments studied

This study looks at how taking aspirin at different times of day affects your body. It aims to understand the best time to take aspirin for heart health and other benefits.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are generally healthy, with well-controlled blood pressure or cholesterol if you have those conditions.
  • Your body mass index (BMI) is between 18 and 30.
  • You have not used tobacco or nicotine products for at least 3 months.
  • You do not take certain medications like pain relievers (aspirin, ibuprofen) or stomach acid reducers, and you have never taken blood thinners.
  • You are willing to avoid alcohol for 48 hours before taking the study drug and during the study.
  • If you are a woman who can become pregnant, you must use birth control and have negative pregnancy tests.
  • You are willing to have blood tests, including for genetics, and a urine test for drugs and nicotine.
  • You do not have a history of bleeding disorders, stomach ulcers, or serious heart, liver, kidney, or other diseases, or cancer in the past 5 years (except for some skin cancers).
  • You have not taken part in another experimental drug or device study recently or donated blood in the past 2 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05265299Recruiting· Phase 3
Testing the right aspirin dose for COPD symptoms

This Phase 3 trial studies which aspirin dose works best in people with COPD, with the goal of improving disease control. You may be asked to take aspirin and be monitored for safety, especially bleeding risk and heart/brain history.

Baltimore, Maryland
NCT05347069Recruiting· Phase 4
Aspirin study for people with stable heart artery disease

This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.

Kyoto
NCT05932472Recruiting· Phase 4
Compare taking aspirin in the morning vs bedtime

This trial studies whether taking your daily aspirin in the morning or at bedtime changes heart and circulation outcomes. It is meant to see if timing matters for people who already take aspirin every day.

Hellerup
NCT07542860Recruiting
Comparing two aspirin doses in older heart disease patients

This study compares whether a lower dose of aspirin (50 mg) works as well as a standard dose (100 mg) for older adults who have had heart attacks, strokes, or other heart and blood vessel problems. The goal is to find the safest effective dose to prevent future events.

Beijing
NCT05702463Recruiting· Phase 1
Daily aspirin in adults with type 2 diabetes

This early-stage study tests how a daily aspirin tablet behaves in the body and how it affects blood/clotting markers in people with type 2 diabetes. It may help researchers understand whether this form of aspirin could be useful, especially if you’re not currently taking aspirin.

Montreal, Quebec
NCT07853248Not yet recruiting· Phase 1
Study of tegoprazan and aspirin interaction in healthy men

This trial studies how two medicines, toprazole and aspirin, interact in healthy men. You'll take both and have your blood tested to see how your body handles them.

Seoul

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.